Production of anti-CD20 intrinsic antibody and its use
A chimeric antibody, a new type of technology, applied in the direction of antibodies, anti-animal/human immunoglobulins, fusion cells, etc., to achieve moderate molecular weight, good clinical application prospects, and good stability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0017] The process of constructing the TGS antibody based on the anti-CD20 monoclonal antibody (1-28) gene is described in detail below, and the activity of the novel antibody is verified through biological experiments. It must be pointed out that this method is not limited to the 1-28 antibody gene preserved in this laboratory, other CD20 antibody genes and other antibody genes that are expected to reduce murine origin can be applied to prepare new antibodies with this structure.
[0018] Design and functional characterization of TGS
[0019] 1. Materials
[0020] The hybridoma cell 1-28 (IgM) secreting anti-CD20 antibody was stored in Beijing Tianguangshi Biotechnology Co., Ltd.
[0021] Daudi, Raji, and 293T cells were subcultured with 10% FCS RPMI-1640 and 10% FCS DMEM (Gibco BRL Company) respectively.
[0022] AMV reverse transcription kit and pGEM -T Easy was purchased from Promega Company.
[0023] The eukaryotic expression vectors pCMV-VH and pCMV-VL used to cons...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com